Cadonilimab combined with taxane and cisplatin as the first-line treatment of advanced esophageal squamous cell carcinoma: an open-label, multicenter phase II trial
Cadonilimab combined with taxane and cisplatin as the first-line treatment of advanced esophageal squamous cell carcinoma: an open-label, multicenter phase II trial
Yijia Guo, Bo Zhang, Mudan Yang, Jing Gao et al.
Citations
2 citations
Journal
Journal for ImmunoTherapy of Cancer
Topics
Esophageal Cancer Research and Treatment
Field-Weighted Citation Impact (FWCI)
4.01
article
Cadonilimab combined with taxane and cisplatin as the first-line treatment of advanced esophageal squamous cell carcinoma: an open-label, multicenter phase II trial
Yijia Guo, Bo Zhang, Mudan Yang, Jing Gao, Siying Guo, Ying Wang, Jing Huang, Wang Qu, Yun Liu
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal for ImmunoTherapy of CancerVol. 13(10)
Institutions
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Chinese PLA General Hospital (CN), Shanxi Provincial Cancer Hospital (CN)